Skip to main content
TipRanks
Go Ultimate75% OFF

Michael Henos Insider Profile

4 Followers

Michael Henos, Director at Crescent Biopharma, holds 504.68K shares in Crescent Biopharma (Ticker: CBIO). Most recently, Michael Henos Sold 21,257 shares of Crescent Biopharma on Dec 23, 2014 for an estimated value of $181.10K.

Michael Henos's Trading History

CBIO
Crescent Biopharma
Dec 23, 2014DirectorInformative Sell181.10K$7.14M
CBIO
Insider Shares: 504.68K (2.65%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 23, 2014Informative Sell$181.10K21,257$8.51+21.80%
Dec 17, 2014Uninformative Sell$60.34K43,626$8.97―
Jun 13, 2014Informative Buy$70.29K11,000$6.39+34.40%
Apr 03, 2014Informative Buy$1.75K1,562$1.12-48.30%
Jan 15, 2014Uninformative Buy$0.00349,515$0.00―

You May Also Like

Michael Henos insider profile FAQ

What is the percentage of profitable transactions made by Michael Henos?
The percentage of profitable transactions made by Michael Henos is 67%.
What is the average return per transaction made by Michael Henos?
The average return per transaction made by Michael Henos is 2.60%.
What stocks does Michael Henos hold?
Michael Henos holds: CBIO stocks.
What was Michael Henos’s latest transaction?
Michael Henos’s latest transaction was an Informative Sell of $181.10K.
What was Michael Henos's most profitable transaction?
Michael Henos’s most profitable transaction was an Informative Buy of CBIO stock on June 13, 2014. The return on the trade was 34.40%.
What is Michael Henos's role in Crescent Biopharma?
Michael Henos's role in Crescent Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.